Home » Topics » Regulatory

Regulatory
RSS

FDA approves carvedilol for reducing risk of myocardial infarction

April 2, 2003

Emend approved by FDA for chemotherapy-induced nausea and vomiting

March 31, 2003

Label extension approved for Cozaar

March 31, 2003

CPMP recommends approval of Busulfex in Europe

March 27, 2003

Launch date set for Finacea

March 24, 2003

Photofrin approved in Canada for HGD associated with Barrett's esophagus

March 24, 2003

Lantus approved in E.U. for pediatric use

March 21, 2003

FDA approves expanded label for Betaseron; ABOVE trial explores increased dose and frequency

March 19, 2003

FDA approves first fusion inhibitor for HIV infection

March 17, 2003

Licensing activity update for Zindaclin

March 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...